Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
Latest Information Update: 29 Dec 2021
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 15 Mar 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 07 Sep 2017 Status changed from active, no longer recruiting to completed.
- 18 Jun 2016 Results assessing population pharmacokinetic from five trials published in the Clinical Pharmacokinetics